Current stock page

Catalysts

VRTX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Sep 4, 2026

VRTX

Catalysts
Vertex Pharmaceuticals Incorporated
Healthcare· Biotechnology
AIQ Score
NeutralAIQ Edge 9/10
Relative Leader / Watch
Strong Relative Position
Score data as of Sep 4, 2026
Last price
$546.12
-$11.84 (-2.12%)
Latest market quote
Momentum72
Value32
Quality82
Risk Resilience62
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 2, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 62/100

Momentum 72/100 and sentiment before the next covered event.

Recent coverage
4 articles

Updated Sep 6, 2026 · Sentiment 7.76%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 72/100AIQ Edge 9/10 Strong Relative Position
Beat rate
50%
4 of 8 reported periods
Average surprise
+1.8%
Across covered historical reports
Latest result
-0.2%
Aug 3, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 3, 2026$4.74$4.73-0.2%$3.23B$3.33B
May 4, 2026$4.24$4.47+5.4%$2.99B$2.99B
Feb 12, 2026$5.11$5.03-1.6%$3.18B$3.19B
Nov 3, 2025$4.57$4.80+5.0%$3.06B$3.08B
Aug 4, 2025$4.29$4.52+5.4%$2.91B$2.96B
May 5, 2025$4.25$4.06-4.5%$2.86B$2.77B
Feb 10, 2025$4.02$3.98-1.0%$2.78B$2.91B
Nov 4, 2024$4.14$4.38+5.8%$2.69B$2.77B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
24
Buy
4
Hold
2
Sell
12-month analyst target
$554.52
+1.54% versus current price
Based on 12 analyst observations. Targets are estimates, not predictions.
Low target
$350.00
-35.91% vs latest price
Average target
$554.52
+1.54% vs latest price
High target
$665.00
+21.77% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 2, 2026

Next known earnings or reporting date.

EPS estimate$4.80

Current analyst expectation for the upcoming report.

Revenue estimate$3.41B

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score72

Where event reaction would show up first.

AIQ score62/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
12
Average target
$554.52
Target upside
1.54%
Target range
$350.00 - $665.00
90-day revisions
3

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
2
Negative
1
finance.yahoo.com · Aug 20, 2026

Are Wall Street Analysts Bullish on Vertex Stock?

Vertex Pharmaceuticals has raced ahead of the market, while analysts continue to give the stock a decidedly optimistic outlook.

insidermonkey.com · Aug 14, 2026

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

On July 29, AbCellera Biologics Inc.

seekingalpha.com · Aug 4, 2026

Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call August 3, 2026 4:30 PM EDTCompany ParticipantsSusie Lisa - Senior Vice President of...

seekingalpha.com · Aug 4, 2026

Vertex Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VRTX) 2026-08-03

2026-08-03. The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2026 Q2 earnings call.

Open full news and sentiment

VRTX Catalysts FAQ

What are the next catalysts for VRTX stock?

VRTX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move VRTX stock?

Upcoming events that could move VRTX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could VRTX's next earnings report affect the stock?

VRTX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive VRTX stock higher?

VRTX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt VRTX stock?

VRTX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.